☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+ Key Biosimilars Events of February 2022
March 3, 2022
Pfizer Receive the US FDA’s Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine for the Prevention of RSV
March 3, 2022
Lexeo Reports Initial Expression and Biomarker Data of LX1001 in P-I/II Clinical Trial for the Treatment of Alzheimer’s Disease
March 3, 2022
SAB Biotherapeutics Discontinues P-III (ACTIV-2) Trial of SAB-185 for the Treatment of COVID-19
March 3, 2022
AmMax Bio Reports Results of AMB-05X in P-II POC Study for the Treatment of Tenosynovial Giant Cell Tumor
March 3, 2022
Oculis Entered into a License Agreement with Accure Therapeutics to Develop and Commercialize ACT-01 for Acute Optic Neuritis and...
March 3, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions